ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50989
0.00%
Bitcoin
60,833.61
0.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Dermata Therapeutics Inc (DRMA)

  7. Dermata Therapeutics Inc (DRMA) News

DRMA

Dermata Therapeutics (DRMA)

Dermata Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRMA
DateTimeSourceHeadlineSymbolCompany
13/01/202408:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
06/01/202413:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202413:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202413:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
06/01/202413:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
18/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
16/12/202309:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DRMADermata Therapeutics Inc
09/12/202309:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRMADermata Therapeutics Inc
08/12/202308:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
30/11/202309:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRMADermata Therapeutics Inc
10/11/202308:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
10/11/202308:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
15/09/202306:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRMADermata Therapeutics Inc
11/08/202306:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
11/08/202306:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
04/08/202306:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
28/07/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
28/07/202306:50Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:DRMADermata Therapeutics Inc
12/07/202323:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRMADermata Therapeutics Inc
08/07/202306:21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
24/06/202306:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DRMADermata Therapeutics Inc
24/06/202306:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DRMADermata Therapeutics Inc
13/06/202307:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DRMADermata Therapeutics Inc
25/05/202307:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
12/05/202306:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DRMADermata Therapeutics Inc
12/05/202306:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
01/04/202307:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
31/03/202307:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
21/03/202321:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRMADermata Therapeutics Inc
21/03/202307:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DRMA

Your Recent History

ASX
ANZ
Australia And New Zealan...
ASX
SUN
Suncorp
NYSE
MRK
Merck
ASX
WDC
Westfield
NYSE
KO
Coca Cola
ASX
WOW
Woolworths
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
FX
GBPAUD
Sterling vs AUD
NASDAQ
AMZN
Amazon.com
ASX
NAB
National Australia Bank
NASDAQ
NVDA
NVIDIA
ASX
RIO
Rio Tinto
ASX
BHP
BHP
ASX
NCM
Newcrest Mining
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved